BioCatalystWatch
ASNDWorkspace / ASND / OverviewCompany library
Price
Market cap
Next catalystExpected Q4 2026YUVIWEL — planned adult achondroplasia trial · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

YORVIPATH (palopegteriparatide)

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

YUVIWEL (navepegritide; TransCon CNP)YUVIWEL — planned adult achondroplasia trial

NPR-B

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

YUVIWEL (navepegritide; TransCon CNP)YUVIWEL — planned adult achondroplasia trial

NPR-B

PreINDP1P3FilingApproved
Upcoming / outlook

YORVIPATH (palopegteriparatide)

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

Partner / License out

Approved / commercial

YUVIWEL (navepegritide; TransCon CNP)

NPR-B

PreINDP1P2P3FilingApproved
Upcoming / outlook

History / paused

TLR7 × TLR8

PreINDP1P2P3FilingApproved
YUVIWEL (navepegritide; TransCon CNP)

NPR-B

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Financial position

Cash and cash equivalents

Source and basis

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ASND SEC archive